;
Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • Cytori gene/cell therapy, musculoskeletal news

    Cytori Therapeutics Inc. (NASDAQ:CYTX; Xetra:XMPA), San Diego, Calif. Business: Gene/Cell therapy, Musculoskeletal Cytori will reduce headcount to about 77 from "a peak of 119 earlier this year" and will focus on its U.…

    Published on 10/6/2014
  • Echo Therapeutics diagnostic news

    Echo Therapeutics Inc. (NASDAQ:ECTE), Philadelphia, Pa. Business: Diagnostic Echo said that it suspended its operations to conserve liquidity and capital resources because the company believes that it has insufficient …

    Published on 10/6/2014
  • Regado Biosciences cardiovascular news

    Regado Biosciences Inc. (NASDAQ:RGDO), Basking Ridge, N.J. Business: Cardiovascular Regado said it will reduce headcount by about 60%, or 20 employees, across all operational sites. Regado said that the staff reduction …

    Published on 10/6/2014
  • Vaxine, GlaxoSmithKline, NIH infectious news

    Vaxine Pty. Ltd., Garran, Australia GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. National Institutes of Health, Bethesda, Md. Business: Infectious NIH's National Institute of Allergy and Infectious Diseases (…

    Published on 10/6/2014
  • Baxter pharmaceuticals, biosimilars news

    Baxter International Inc. (NYSE:BAX), Deerfield, Ill. Business: Pharmaceuticals, Biosimilars Baxter said the name of the new public biopharma company that will emerge from the split of its business will be Baxalta Inc. …

    Published on 9/29/2014
  • BioCryst, NIH infectious news

    BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX), Durham, N.C. National Institutes of Health, Bethesda, Md. Business: Infectious BioCryst said NIH's National Institute of Allergy and Infectious Disease (NIAID) modified a …

    Published on 9/29/2014
  • Broad Institute, Harvard Medical School, Icahn School of Medicine at Mount Sinai, NIH, Oregon Health and Science University (OHSU), University of California bioinformatics, computational chemistry ...

    Broad Institute of MIT and Harvard, Cambridge, Mass. Harvard Medical School, Boston, Mass. Icahn School of Medicine at Mount Sinai, New York, N.Y. National Institutes of Health, Bethesda, Md. Oregon Health and Science …

    Published on 9/29/2014
  • Eli Lilly, Takeda endocrine/metabolic news

    Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Endocrine/Metabolic A judge in the U.S. District Court for the Western District of Louisiana issued a…

    Published on 9/29/2014
  • Eutropics, NIH pharmacogenetics news

    Eutropics Pharmaceuticals Inc., Cambridge, Mass. National Institutes of Health, Bethesda, Md. Business: Pharmacogenetics Eutropics said it received a $1.5 million Small Business Innovation Research (SBIR) contract from …

    Published on 9/29/2014
  • Genetic Technologies diagnostic news

    Genetic Technologies Ltd. (ASX:GTG; NASDAQ:GENE), Fitzroy, Australia Business: Diagnostic Genetic Technologies announced plans to restructure and realign activities to focus on the U.S. molecular diagnostics market and …

    Published on 9/29/2014
  • Genocea, Bill & Melinda Gates Foundation infectious news

    Genocea Biosciences Inc. (NASDAQ:GNCA), Cambridge, Mass. Bill & Melinda Gates Foundation, Seattle, Wash. Business: Infectious Genocea received a $1.2 million grant from the Gates Foundation to identify protective T cell…

    Published on 9/29/2014
  • International Progressive MS Alliance autoimmune news

    International Progressive MS Alliance, London, U.K. Business: Autoimmune The International Progressive MS Alliance has awarded its first round of 22 research grants to investigators at research universities and …

    Published on 9/29/2014
  • Novavax, U.S. Department of Health and Human Services infectious news

    Novavax Inc. (NASDAQ:NVAX), Rockville, Md. U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious Novavax said HHS's Biomedical Advanced Research and Development Authority (BARDA) exercised …

    Published on 9/29/2014
  • PharmAthene, NIH infectious news

    PharmAthene Inc. (NYSE-M:PIP), Annapolis, Md. National Institutes of Health, Bethesda, Md. Business: Infectious PharmAthene received a contract worth up to $28.1 million from NIH's National Institute of Allergy and …

    Published on 9/29/2014
  • Silarus Therapeutics Inc., Thyritope Biosciences Inc., GlaxoSmithKline hematology, endocrine/metabolic, autoimmune news

    Silarus Therapeutics Inc., San Diego, Calif. Thyritope Biosciences Inc., San Diego, Calif. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Hematology, Endocrine/Metabolic, Autoimmune Avalon Ventures and …

    Published on 9/29/2014
  • Tekmira, Wellcome Trust infectious news

    Tekmira Pharmaceuticals Corp. (TSX:TKM; NASDAQ:TKMR), Burnaby, B.C. Wellcome Trust, London, U.K. Business: Infectious Tekmira joined a consortium to conduct clinical trials of Ebola virus therapeutics in West Africa. …

    Published on 9/29/2014
  • Tengion gene/cell therapy, transplant news

    Tengion Inc. (OTCQB:TNGN), Winston-Salem, N.C. Business: Gene/Cell therapy, Transplant Regenerative medicine company Tengion hired Jefferies to explore strategic options. Tengion said the decision allows it to realize …

    Published on 9/29/2014
  • Accel-Rx Health Sciences Accelerator finance news

    Accel-Rx Health Sciences Accelerator, Vancouver, B.C. Business: Finance Accel-Rx, a pan-Canadian health sciences accelerator, announced its official launch after receiving a C$14.5 million ($13.1 million) award from the…

    Published on 9/22/2014
  • Aegerion endocrine/metabolic news

    Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR), Cambridge, Mass. Business: Endocrine/Metabolic Aegerion said it resolved a warning letter from FDA's Office of Prescription Drug Promotion regarding statements CEO Marc Beer…

    Published on 9/22/2014
  • Bayer pharmaceuticals, other news

    Bayer AG (Xetra:BAYN), Leverkusen, Germany Business: Pharmaceuticals, Other Bayer said it will focus on its life science businesses and spin out its material sciences division, Bayer MaterialScience, into a separate …

    Published on 9/22/2014
  • GlaxoSmithKline, COPD Foundation, Global Initiative for Chronic Obstructive Lung Disease (GOLD) pulmonary news

    GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. COPD Foundation, Washington, D.C. Global Initiative for Chronic Obstructive Lung Disease (GOLD), Vancouver, Wash. Business: Pulmonary GlaxoSmithKline, GOLD and the …

    Published on 9/22/2014
  • GlaxoSmithKline pharmaceuticals news

    GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Pharmaceuticals The Changsha Intermediate People's Court in Hunan Province found GlaxoSmithKline's GSK China Investment Co. Ltd. subsidiary guilty of …

    Published on 9/22/2014
  • Hemispherx, Swiss Federal Department of Defense, Civil Protection and Sports (DDPS) infectious news

    Hemispherx Biopharma Inc. (NYSE-M:HEB), Philadelphia, Pa. Swiss Federal Department of Defense, Civil Protection and Sports (DDPS), Bern, Switzerland Business: Infectious Hemispherx expanded a research deal with the …

    Published on 9/22/2014
  • InDevR, U.S. Department of Health and Human Services diagnostic news

    InDevR Inc., Boulder, Colo. U.S. Department of Health and Human Services, Washington, D.C. Business: Diagnostic InDevR said HHS's Biomedical Advanced Research and Development Authority (BARDA) awarded the company a $14.…

    Published on 9/22/2014
  • Merck KGaA biosimilars news

    Merck KGaA (Xetra:MRK), Darmstadt, Germany Business: Biosimilars Merck said it would invest EUR130 - EUR150 million ($168.2-$194.1 million) in biosimilars during 2015, depending on the outcome of ongoing Phase I studies…

    Published on 9/22/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993